The effect of type 2 diabetes genetic predisposition on non-cardiovascular comorbidities
Arruda, A. L.; Wood, A. C.; Taylor, H. J.; Bocher, O.; Yoshiji, S.; Yin, X.; Zhao, C.; Chen, J.; Cammann, D.; Suzuki, K.; Mercader, J. M.; Spracklen, C. N.; Meighs, J. B.; Vujkovic, M.; Davey Smith, G.; Rotter, J.; Voight, B. F.; Morris, A. P.; Zeggini, E.
Show abstract
Type 2 diabetes (T2D) is epidemiologically associated with a wide range of non-cardiovascular comorbidities, yet their shared etiology has not been fully elucidated. Leveraging eight non-overlapping mechanistic clusters of T2D genetic profiles, each representing distinct biological pathways, we investigate putative causal links between cluster-stratified T2D genetic predisposition and 21 non-cardiovascular comorbidities. Most of the identified putative causal effects are driven by distinct T2D genetic clusters. For example, the risk-increasing effects of T2D genetic predisposition on cataracts and erectile dysfunction are primarily attributed to obesity and glucose regulation mechanisms, respectively. When surveyed in populations across the globe, we observe opposing effect directions for depression, asthma and chronic obstructive pulmonary disease between populations. We identify a putative causal link between T2D genetic predisposition and osteoarthritis. To underscore the translational potential of our findings, we intersect high-confidence effector genes for osteoarthritis with targets of T2D-approved drugs and identify metformin as a potential candidate for drug repurposing in osteoarthritis.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Differentially expressed genes reflect disease-induced rather than disease-causing changes in the transcriptome 96%
- A unified framework for estimating country-specific cumulative incidence for 18 diseases stratified by polygenic risk 95%
- Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities 94%
Similar papers in this journal
- Genome-wide analysis in 756,646 individuals provides first genetic evidence that ACE2 expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease 93%
- A combined polygenic score of 21,293 rare and 22 common variants significantly improves diabetes diagnosis based on hemoglobin A1C levels 93%
- Rare variant association analysis in 51,256 type 2 diabetes cases and 370,487 controls informs the spectrum of pathogenicity of monogenic diabetes genes 93%
Similar papers in this journal
- Leveraging genomic diversity for discovery in an EHR-linked biobank: the UCLA ATLAS Community Health Initiative 93%
- The genetic case for cardiorespiratory fitness as a clinical vital sign and the routine prescription of physical activity in healthcare 93%
- Validation of a Trans-Ancestry Polygenic Risk Score for Type 2 Diabetes in Diverse Populations 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.